scholarly article | Q13442814 |
P50 | author | Ashish Sharma | Q57334406 |
Ritambhra Nada | Q71636749 | ||
Vivekanand Jha | Q38800410 | ||
P2093 | author name string | R Ramachandran | |
V Sakhuja | |||
M Rathi | |||
K Joshi | |||
K L Gupta | |||
H S Kohli | |||
M Minz | |||
P2860 | cites work | Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression | Q46825318 |
Cancers complicating organ transplantation | Q68613885 | ||
Pretransplantation assessment of the risk of lymphoproliferative disorder | Q71910946 | ||
Twenty and 25 years survival after cadaveric renal transplantation | Q72339348 | ||
Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients | Q72659857 | ||
Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome | Q78534522 | ||
Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis | Q82996536 | ||
Lymphoproliferative disorders in renal transplant recipients: a single-centre experience | Q82999899 | ||
Lymphoproliferative disorders in Oxford renal transplant recipients | Q35586818 | ||
The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders | Q35680531 | ||
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression | Q35818660 | ||
Lymphoproliferative disease after renal transplantation in Australia and New Zealand | Q36205802 | ||
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients | Q40625214 | ||
Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. | Q40834086 | ||
Incidence and consequences of post-transplantation lymphoproliferative disorders | Q41546087 | ||
Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant | Q44116989 | ||
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation | Q44662215 | ||
Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? | Q45755509 | ||
Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. | Q46006774 | ||
Post-transplant lymphoproliferative disorders after live donor renal transplantation | Q46690570 | ||
P433 | issue | 4 | |
P921 | main subject | India | Q668 |
lymphoproliferative disorders | Q4165484 | ||
P304 | page(s) | 287-291 | |
P577 | publication date | 2013-07-01 | |
P1433 | published in | Indian Journal of Nephrology | Q6020793 |
P1476 | title | Spectrum of lymphoproliferative disorders following renal transplantation in North India | |
P478 | volume | 23 |
Q55339839 | Carcinoma of the Tongue in Renal Transplant Recipients: An Unusual Spectrum of De novo Malignancy at a Tertiary Care Center in India Over a Period of 26 Years. |
Q39501295 | Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation |
Q57123042 | Late Posttransplant Lymphoproliferative Disease: Report of a Rare Case and Role of Positron Emission Tomography-computed Tomography |
Q57123093 | Posttransplant Lymphoproliferative Disorder: Experience from a Pediatric Nephrology Unit in North India |
Search more.